BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 9601674)

  • 1. Effects of combined BDNF and GDNF treatment on cultured dopaminergic midbrain neurons.
    Sautter J; Meyer M; Spenger C; Seiler RW; Widmer HR
    Neuroreport; 1998 Apr; 9(6):1093-6. PubMed ID: 9601674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spatial and temporal growth factor influences on developing midbrain dopaminergic neurons.
    Engele J
    J Neurosci Res; 1998 Aug; 53(4):405-14. PubMed ID: 9710260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rat fetal ventral mesencephalon grown as solid tissue cultures: influence of culture time and BDNF treatment on dopamine neuron survival and function.
    Höglinger GU; Sautter J; Meyer M; Spenger C; Seiler RW; Oertel WH; Widmer HR
    Brain Res; 1998 Dec; 813(2):313-22. PubMed ID: 9838177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Additive effect of glial cell line-derived neurotrophic factor and neurotrophin-4/5 on rat fetal nigral explant cultures.
    Meyer M; Matarredona ER; Seiler RW; Zimmer J; Widmer HR
    Neuroscience; 2001; 108(2):273-84. PubMed ID: 11734360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glial cell line-derived neurotrophic factor is expressed in the developing but not adult striatum and stimulates developing dopamine neurons in vivo.
    Strömberg I; Björklund L; Johansson M; Tomac A; Collins F; Olson L; Hoffer B; Humpel C
    Exp Neurol; 1993 Dec; 124(2):401-12. PubMed ID: 7904571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of donor age and brain-derived neurotrophic factor on the survival of dopaminergic neurons and axonal growth in postnatal rat nigrostriatal cocultures.
    Ostergaard K; Jones SA; Hyman C; Zimmer J
    Exp Neurol; 1996 Dec; 142(2):340-50. PubMed ID: 8934565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of time in culture and BDNF pretreatment on survival and function of grafted embryonic rat ventral mesencephalon in the 6-OHDA rat model of Parkinson's disease.
    Höglinger GU; Widmer HR; Spenger C; Meyer M; Seiler RW; Oertel WH; Sautter J
    Exp Neurol; 2001 Jan; 167(1):148-57. PubMed ID: 11161602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CGP 3466 increases survival of cultured fetal dopaminergic neurons.
    Matarredona ER; Meyer M; Seiler RW; Widmer HR
    Restor Neurol Neurosci; 2003; 21(1-2):29-37. PubMed ID: 12808200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The response of human and rat fetal ventral mesencephalon in culture to the brain-derived neurotrophic factor treatment.
    Zhou J; Bradford HF; Stern GM
    Brain Res; 1994 Sep; 656(1):147-56. PubMed ID: 7804829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased survival of dopaminergic neurons in striatal grafts of fetal ventral mesencephalic cells exposed to neurotrophin-3 or glial cell line-derived neurotrophic factor.
    Espejo M; Cutillas B; Arenas TE; Ambrosio S
    Cell Transplant; 2000; 9(1):45-53. PubMed ID: 10784066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glial cell line-derived neurotrophic factor supports survival of injured midbrain dopaminergic neurons.
    Bowenkamp KE; Hoffman AF; Gerhardt GA; Henry MA; Biddle PT; Hoffer BJ; Granholm AC
    J Comp Neurol; 1995 May; 355(4):479-89. PubMed ID: 7636027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parallel induction of the formation of dopamine and its metabolites with induction of tyrosine hydroxylase expression in foetal rat and human cerebral cortical cells by brain-derived neurotrophic factor and glial-cell derived neurotrophic factor.
    Theofilopoulos S; Goggi J; Riaz SS; Jauniaux E; Stern GM; Bradford HF
    Brain Res Dev Brain Res; 2001 Apr; 127(2):111-22. PubMed ID: 11334998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth factors improve immediate survival of embryonic dopamine neurons after transplantation into rats.
    Zawada WM; Zastrow DJ; Clarkson ED; Adams FS; Bell KP; Freed CR
    Brain Res; 1998 Mar; 786(1-2):96-103. PubMed ID: 9554968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved survival of embryonic porcine dopaminergic neurons in coculture with a conditionally immortalized GDNF-producing hippocampal cell line.
    Meyer M; Johansen J; Gramsbergen JB; Johansen TE; Zimmer J
    Exp Neurol; 2000 Jul; 164(1):82-93. PubMed ID: 10877918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of GDNF and BDNF on cultured ventral mesencephalic neurons.
    Feng L; Wang CY; Jiang H; Oho C; Mizuno K; Dugich-Djordjevic M; Lu B
    Brain Res Mol Brain Res; 1999 Mar; 66(1-2):62-70. PubMed ID: 10095078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glial cell line-derived neurotrophic factor stimulates the morphological differentiation of cultured ventral mesencephalic calbindin- and calretinin-expressing neurons.
    Widmer HR; Schaller B; Meyer M; Seiler RW
    Exp Neurol; 2000 Jul; 164(1):71-81. PubMed ID: 10877917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of BDNF on dopaminergic, serotonergic, and GABAergic neurons in cultures of human fetal ventral mesencephalon.
    Spenger C; Hyman C; Studer L; Egli M; Evtouchenko L; Jackson C; Dahl-Jørgensen A; Lindsay RM; Seiler RW
    Exp Neurol; 1995 May; 133(1):50-63. PubMed ID: 7601263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GDNF increases the density of cells containing calbindin but not of cells containing calretinin in cultured rat and human fetal nigral tissue.
    Meyer M; Zimmer J; Seiler RW; Widmer HR
    Cell Transplant; 1999; 8(1):25-36. PubMed ID: 10338273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions of cyclic adenosine monophosphate, brain-derived neurotrophic factor, and glial cell line-derived neurotrophic factor treatment on the survival and growth of postnatal mesencephalic dopamine neurons in vitro.
    Lara J; Kusano K; House S; Gainer H
    Exp Neurol; 2003 Mar; 180(1):32-45. PubMed ID: 12668147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minor immunoreactivity in GDNF-, BDNF-, or NT-3-treated substantia nigra allografts.
    Shinoda M; Hoffer BJ; Olson L
    J Neural Transplant Plast; 1997; 6(2):83-96. PubMed ID: 9306240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.